SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $514,000 | +56.2% | 34,293 | +26.9% | 0.00% | +100.0% |
| Q1 2016 | $329,000 | -21.5% | 27,025 | +2.5% | 0.00% | 0.0% |
| Q4 2015 | $419,000 | +16.1% | 26,365 | +12.0% | 0.00% | 0.0% |
| Q3 2015 | $361,000 | -34.4% | 23,545 | +4.1% | 0.00% | -50.0% |
| Q2 2015 | $550,000 | -5.3% | 22,609 | -9.5% | 0.00% | 0.0% |
| Q1 2015 | $581,000 | +5.4% | 24,974 | +13.9% | 0.00% | 0.0% |
| Q4 2014 | $551,000 | -19.7% | 21,924 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $686,000 | +21.6% | 22,049 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $564,000 | +75.2% | 21,799 | +58.2% | 0.00% | +100.0% |
| Q1 2014 | $322,000 | -13.0% | 13,781 | -5.6% | 0.00% | 0.0% |
| Q4 2013 | $370,000 | +25.0% | 14,591 | +0.7% | 0.00% | 0.0% |
| Q3 2013 | $296,000 | -3.6% | 14,491 | -1.0% | 0.00% | 0.0% |
| Q2 2013 | $307,000 | – | 14,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |